Polydex Pharmaceuticals Story

POLXFDelisted Stock  USD 1.99  0.00  0.00%   
Roughly 56% of Polydex Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Polydex Pharmaceuticals pink sheet suggests that many investors are alarmed at this time. Polydex Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Polydex Pharmaceuticals. The current market sentiment, together with Polydex Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Polydex Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Polydex Pharmaceuticals pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Polydex daily returns and investor perception about the current price of Polydex Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Polydex Pharmaceuticals.

Polydex Pharmaceuticals Latest Timeline

Polydex Pharmaceuticals is listed for 1.99. The company has price-to-book ratio of 0.42. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Polydex Pharmaceuticals recorded a loss per share of 0.13. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 23rd of June 1997.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Consideration for investing in Polydex Pink Sheet

If you are still planning to invest in Polydex Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Polydex Pharmaceuticals' history and understand the potential risks before investing.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Global Correlations
Find global opportunities by holding instruments from different markets
CEOs Directory
Screen CEOs from public companies around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.